Spitomin

Medicinal product

(Invented) name

Spitomin

Active substance (s)

Buspironas

Strength

5 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05BE01, Buspirone

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-09-15

Date of renewal

Documents

2866_2867_Spitomin 5mg_10mg_tab_PL_2025-09-15.docx

2866_2867_Spitomin 5mg_10mg_tab_PZ_2025-09-15.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Buspironas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118637	104741	1104741	lizdinė plokštelė	N60		Receptinis	LT/L/25/2866/001	Netiekiama	-	2025-11-20	No	-	-	Download

Stadijos

Data	Stadija
2025-09-15	Registruotas